Sort
23,748 grants matching “melanoma”
The Oncogene Activated Mitochondrial Unfolded Protein Response Regulates Senescence Biology
$552,538Jerry Edward Chipuk · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
Mechanisms of Murine Turmor Eradication by Immunotherapy
$552,495Philip D Greenberg · University Of Washington · R01 · FY2013 · CA
THERAPEUTIC MANUFACTURING
$552,471Leland H Hartwell · Fred Hutchinson Cancer Research Center · P30 · FY2012 · CA
Dissecting single cell dynamics that coordinate neural crest migration and diversification
$552,433Thomas F Schilling · University Of California-Irvine · R01 · FY2023 · DE
Dissecting single cell dynamics that coordinate neural crest migration and diversification
$552,433Thomas F Schilling · University Of California-Irvine · R01 · FY2025 · DE
Characterization of Pigmentary Disorders and Melanoma Targeting
$552,336Vincent J Hearing · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
MITF from control of pigmentation to melanoma risk
$552,287David E Fisher · Massachusetts General Hospital · R01 · FY2023 · AR
Integrated Discovery Pipeline for Tumor Neoantigens
$552,250Beatriz M. Carreno · University Of Pennsylvania · R01 · FY2018 · CA
Identification and assessment of unconventional tumor-associated antigens as potential targets for cytotoxic T-cell based immunotherapy of cancer
$552,182Gregory A Lizee · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Optimizing Novel Immunotherapy Combinations Targeting the Tumor Microenvironment in Canine Spontaneous Osteosarcoma
$552,171Steven W. Dow · Colorado State University · U01 · FY2022 · CA
Upgrading rigor and efficiency of germline cancer gene variant classification for the 2020s
$552,001Sean Vahram Tavtigian · Utah State Higher Education System--University Of Utah · R01 · FY2025 · CA
ITIM-receptors for cancer treatment
$551,973Chengcheng Zhang · Ut Southwestern Medical Center · R01 · FY2024 · CA
Neoadjuvant Immunotherapy with Intratumoral CPG and PD-1 Blockade in Melanoma
$551,927Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
Genetic Loss-of-Function Studies of SETD2 in Kidney Tumorigenesis
$551,891Emily H Cheng · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA
Functional Networks for Persister Cell Sensitivities
$551,800Michael T McManus · University Of California, San Francisco · R01 · FY2018 · CA
Congenic Mouse Medels of Melanoma for the Characterization of Tumor Immune Responses
$551,750Marcus W Bosenberg · Yale University · R01 · FY2018 · CA
Congenic Mouse Medels of Melanoma for the Characterization of Tumor Immune Responses
$551,750Marcus W Bosenberg · Yale University · R01 · FY2017 · CA
Rewiring Pathways and Networks by Environmental Perturbations
$551,631Marc Vidal · Dana-Farber Cancer Inst · R01 · FY2010 · ES
Elucidation of novel anti-angiogenic therapies for the prevention and treatment of neovascular glaucoma
$551,625Silvia V Montaner · University Of Maryland Baltimore · R01 · FY2021 · EY
Low Dose Interleukin-2 for Regulatory T cell Modulation and the Treatment of Crohn's Disease
$551,543Scott B Snapper · Boston Children'S Hospital · R01 · FY2022 · DK
Differential TGF-Beta Signaling in Bone Microenviroment: Impact on Tumor Growth
$551,442Theresa A Guise · Indiana University Indianapolis · U01 · FY2011 · CA
Regulation of Ras-Dependent Signal Transduction Pathways
$551,428Deborah Morrison · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Response and Acquired Resistance to PD-1 Blockade
$551,291Antoni Ribas · University Of California Los Angeles · R01 · FY2015 · CA
Precision Medicine For Pediatric Low-Grade Gliomas
$551,281Daphne A. Haas-Kogan · Dana-Farber Cancer Inst · R01 · FY2015 · NS
Canine models for characterization, diagnosis, and treatment of human cancers using comparative canine-human transcriptomics
$551,264Gregory Tawa · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR